The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2020

Filed:

Mar. 16, 2018
Applicant:

Bayer Intellectual Property Gmbh, Monheim, DE;

Inventors:

Antje Kahnert, Wuppertal, DE;

Kerstin Unterschemmann, Wuppertal, DE;

Iring Heisler, Düsseldorf, DE;

Charlotte Christine Kopitz, Berlin, DE;

Joachim Schuhmacher, Wuppertal, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/30 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 47/6803 (2017.08); A61K 47/6851 (2017.08); C07K 2317/14 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01);
Abstract

The present invention provides immunoconjugates composed of antibodies, e.g., monoclonal antibodies, or antibody fragments that bind to mesothelin, that are conjugated to cytotoxic agents, e.g., maytansine, or derivatives thereof, and/or co-administered or formulated with one or more additional anti-cancer agents. The immunoconjugates of the invention can be used in the methods of the invention to treat and/or diagnose and/or monitor cancers, e.g. solid tumors, recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for the membrane-anchored, 40 kDa mesothelin polypeptide, which is overexpressed in several tumors, such as pancreatic and ovarian tumors, mesothelioma and lung cancer cells.


Find Patent Forward Citations

Loading…